The GSH uptake carries on by two enzymes on the cell surfaces
Combination with finerenone for cardiorenal protection Recently, in FIDELIO-DKD [52], FIGARO-DKD [53] and their pooled meta-analysis FIDELITY [11], finerenone has also been shown to reduce cardiovascular and renal events in CKD patients with diabetes
BerberTrim complements this by targeting key metabolic pathways with 1,000 mg of berberine plus clinically studied nutrients that support healthy blood sugar, GLP-1 activity, and lipid metabolism to reduce fat storage and boost energy utilization
One GLP-1RA, liraglutide, has been approved to treat obesity, and another, semaglutide, is in clinical trials
The combination of these two mechanisms may form a better antimalarial therapy